HOME

Sanger Sequencing

GATC Biotech has its roots deep in the field of Sanger sequencing. Founded in 1990, the company commercialised the first nonradioactive sequencing technology platform, Direct-Blotting-Electrophoresis-System GATC 1500.

NextGen Sequencing

Genomic innovation – Made in Germany
GATC Biotech offers all leading sequencing technologies in its own laboratories. The company’s proprietary workflows deliver high-quality results backed by ISO 17025 accreditation and ISO 13485 certification.

GATCLIQUID

The X-ray of the 21^st century
Our liquid biopsy-based service line offers cancer characterisation from a simple blood sample.

MYCOPLASMACHECK

Reliable and sensitive service for the detection of all relevant mycoplasma contaminations for close quality control of cell cultures.

Liquid biopsy in cancer research

GATC Biotech is the first service provider to offer access to liquid biopsy-based assays with unprecedented flexibility for any stage or any project of blood-based tumour characterisation. Learn more now.

Looking for partners?

GATC Biotech, a family-owned SME, has participated in a large number of successful publicly funded research projects. Our expertise and the high quality of our work are your guarantee for scientific progress in any kind of collaboration. Strive for genomic innovation and learn more about current publicly funded project.

Why GATC Biotech

GATC Biotech, a family- owned business since 1990, is Europe’s leading sequencing services provider with more than 10,000 customers from academia, healthcare and industry worldwide.

Featured events:

June 21

ISFMS - 2nd International Symposium on Frontiers in Molecular Science - Non-Coding RNAs and Epigenetics in Cancer

Basel, Switzerland | June 21

ISFMS - 2nd International Symposium on Frontiers in Molecular Science - Non-Coding RNAs and Epigenetics in Cancer

GATC to be part of Eurofins Group

Constance, Germany, June 2nd, 2017: GATC, one of the leading sequencing provider will be a part of the Eurofins Group as of July 2017 to create the leading company in the worldwide sequencing market.Eurofins Scientific (EUFI.PA), a global leader in...

GATC Biotech launches most comprehensive cancer panel for profiling of any tumour type

Constance, Germany, May 23, 2017: GATC Biotech, a leading worldwide provider of sequencing services, announced today the launch of ONCOPANEL ALL-IN-ONE, the most comprehensive cancer gene panel for liquid biopsy and tissue biopsy samples to date. The...